- Inicio
- Publicaciones
- Obecabtagene autoleucel (obe-cel, AUTO1) in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): Overall survival (OS), event-free survival (EFS) and the potential impact of chimeric antigen receptor (CAR)-T cell persistency and consolidative stem cell transplantation (SCT) in the open-label, single-arm FELIX phase Ib/II study
Obecabtagene autoleucel (obe-cel, AUTO1) in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): Overall survival (OS), event-free survival (EFS) and the potential impact of chimeric antigen receptor (CAR)-T cell persistency and consolidative stem cell transplantation (SCT) in the open-label, single-arm FELIX phase Ib/II study
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Jabbour, E
- Tholouli, E
- Sandhu, KS
- Shaughnessy, P
- Barba, P
- Yallop, D
- Logan, A
- Abedi, M
- Lao-Sirieix, P
- Zhang, YY
- Brugger, W
- Pule, MA
- Shah, BD
- Bishop, MR
- Park, JH
- DeAngelo, DJ
- Peggs, K
- Roddie, C
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Jabbour,E,Tholouli,E,Sandhu,KS,Shaughnessy,P,Barba,P,Guerreiro,M,Yallop,D et al. Obecabtagene autoleucel (obe-cel, AUTO1) in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): Overall survival (OS), event-free survival (EFS) and the potential impact of chimeric antigen receptor (CAR)-T cell persistency and consolidative stem cell transplantation (SCT) in the open-label, single-arm FELIX phase Ib/II study. Special Clinical Science Symposia. 2024. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2024.
Portal de investigación